Feedback / Questions
ORIC-944 - ORIC Pharma
https://www.globenewswire.com/news-release/2025/05/28/3089929/0/en/ORIC-Pharmaceuticals-Announces-Potentially-Best-In-Class-Preliminary-Efficacy-and-Safety-Data-from-Ongoing-Phase-1b-Trial-of-ORIC-944-in-Combination-with-AR-Inhibitors-for-the-Trea.html
May 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next